223 related articles for article (PubMed ID: 25374033)
21. Shift of microRNA profile upon glioma cell migration using patient-derived spheroids and serum-free conditions.
Munthe S; Halle B; Boldt HB; Christiansen H; Schmidt S; Kaimal V; Xu J; Zabludoff S; Mollenhauer J; Poulsen FR; Kristensen BW
J Neurooncol; 2017 Mar; 132(1):45-54. PubMed ID: 28091986
[TBL] [Abstract][Full Text] [Related]
22. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.
Cheng ZX; Song YX; Wang ZY; Wang Y; Dong Y
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4079-4086. PubMed ID: 29028093
[TBL] [Abstract][Full Text] [Related]
23. Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.
Tivnan A; Heilinger T; Ramsey JM; O'Connor G; Pokorny JL; Sarkaria JN; Stringer BW; Day BW; Boyd AW; Kim EL; Lode HN; Cryan SA; Prehn JH
Oncotarget; 2017 Mar; 8(10):16605-16620. PubMed ID: 28178667
[TBL] [Abstract][Full Text] [Related]
24. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of EGFR induces a c-MET-driven stem cell population in glioblastoma.
Jun HJ; Bronson RT; Charest A
Stem Cells; 2014 Feb; 32(2):338-48. PubMed ID: 24115218
[TBL] [Abstract][Full Text] [Related]
26. The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle.
Liu DZ; Cheng Y; Cai RQ; Wang Bd WW; Cui H; Liu M; Zhang BL; Mei QB; Zhou SY
Nanomedicine; 2018 Apr; 14(3):991-1003. PubMed ID: 29339188
[TBL] [Abstract][Full Text] [Related]
27. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
28. Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery.
Yoon DJ; Kwan BH; Chao FC; Nicolaides TP; Phillips JJ; Lam GY; Mason AB; Weiss WA; Kamei DT
Cancer Res; 2010 Jun; 70(11):4520-7. PubMed ID: 20460527
[TBL] [Abstract][Full Text] [Related]
29. Growth of glioblastoma is inhibited by miR-133-mediated EGFR suppression.
Xu F; Li F; Zhang W; Jia P
Tumour Biol; 2015 Dec; 36(12):9553-8. PubMed ID: 26138587
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1.
Kouhkan F; Mobarra N; Soufi-Zomorrod M; Keramati F; Hosseini Rad SM; Fathi-Roudsari M; Tavakoli R; Hajarizadeh A; Ziaei S; Lahmi R; Hanif H; Soleimani M
J Med Genet; 2016 Jan; 53(1):24-33. PubMed ID: 26510428
[TBL] [Abstract][Full Text] [Related]
31. MiR-615 inhibits cell proliferation, migration and invasion by targeting EGFR in human glioblastoma.
Ji Y; Sun Q; Zhang J; Hu H
Biochem Biophys Res Commun; 2018 May; 499(3):719-726. PubMed ID: 29605294
[TBL] [Abstract][Full Text] [Related]
32. Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia.
Jin Y; Liu S; Yu B; Golan S; Koh CG; Yang J; Huynh L; Yang X; Pang J; Muthusamy N; Chan KK; Byrd JC; Talmon Y; Lee LJ; Lee RJ; Marcucci G
Mol Pharm; 2010 Feb; 7(1):196-206. PubMed ID: 19852511
[TBL] [Abstract][Full Text] [Related]
33. Polymeric nanoparticle mediated inhibition of miR-21 with enhanced miR-124 expression for combinatorial glioblastoma therapy.
Liu Y; Zheng M; Jiao M; Yan C; Xu S; Du Q; Morsch M; Yin J; Shi B
Biomaterials; 2021 Sep; 276():121036. PubMed ID: 34329919
[TBL] [Abstract][Full Text] [Related]
34. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
[TBL] [Abstract][Full Text] [Related]
35. Dual Functional MicroRNA-186-5p Targets both FGF2 and RelA to Suppress Tumorigenesis of Glioblastoma Multiforme.
Wang F; Jiang H; Wang S; Chen B
Cell Mol Neurobiol; 2017 Nov; 37(8):1433-1442. PubMed ID: 28213656
[TBL] [Abstract][Full Text] [Related]
36. Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice.
Yhee JY; Lee SJ; Lee S; Song S; Min HS; Kang SW; Son S; Jeong SY; Kwon IC; Kim SH; Kim K
Bioconjug Chem; 2013 Nov; 24(11):1850-60. PubMed ID: 24107100
[TBL] [Abstract][Full Text] [Related]
37. miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma.
Zuo J; Yu H; Xie P; Liu W; Wang K; Ni H
Gene; 2019 Aug; 710():233-239. PubMed ID: 31181312
[TBL] [Abstract][Full Text] [Related]
38. miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.
Fowler A; Thomson D; Giles K; Maleki S; Mreich E; Wheeler H; Leedman P; Biggs M; Cook R; Little N; Robinson B; McDonald K
Eur J Cancer; 2011 Apr; 47(6):953-63. PubMed ID: 21196113
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma.
Xu G; Li JY
Tumour Biol; 2016 Aug; 37(8):10577-86. PubMed ID: 26857280
[TBL] [Abstract][Full Text] [Related]
40. Delivery of Antisense Oligonucleotide LOR-2501 Using Transferrin-conjugated Polyethylenimine-based Lipid Nanoparticle.
Zheng B; Yang S; Tian Q; Xie Y; Zhang S; Lee RJ
Anticancer Res; 2019 Apr; 39(4):1785-1793. PubMed ID: 30952718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
